NASDAQ:FWP
Delisted
Forward Pharma A/S Stock News
$1.95
+0 (+0%)
At Close: Apr 18, 2023
Forward Pharma granted Australian patent linked to multiple sclerosis therapy
04:49pm, Thursday, 23'rd Dec 2021 Seeking AlphaShort Interest in Forward Pharma A/S (NASDAQ:FWP) Decreases By 31.0%
12:26am, Monday, 20'th Dec 2021 Dakota Financial News
Forward Pharma A/S (NASDAQ:FWP) was the recipient of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 73,100 shares, a drop of 31.0% from the November 15th total of 105,900 shares. Approximately 1.1% of the shares of the company are short sold. Based on []
Forward Pharma A/S (NASDAQ:FWP) Sees Large Growth in Short Interest
09:54am, Saturday, 04'th Dec 2021 Dakota Financial News
Forward Pharma A/S (NASDAQ:FWP) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 105,900 shares, a growth of 39.5% from the October 31st total of 75,900 shares. Currently, 1.6% of the companys stock are sold short. Based on an average []
Short Interest in Forward Pharma A/S (NASDAQ:FWP) Declines By 29.1%
04:50pm, Saturday, 20'th Nov 2021 Transcript Daily
Forward Pharma A/S (NASDAQ:FWP) saw a large drop in short interest in October. As of October 29th, there was short interest totalling 75,900 shares, a drop of 29.1% from the October 14th total of 107,000 shares. Based on an average daily trading volume, of 133,500 shares, the days-to-cover ratio is currently 0.6 days. Approximately 1.1% []
Forward Pharma A/S (NASDAQ:FWP) Stock Passes Above 50 Day Moving Average of $6.76
08:10am, Wednesday, 17'th Nov 2021 Dakota Financial News
Shares of Forward Pharma A/S (NASDAQ:FWP) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $6.76 and traded as high as $6.77. Forward Pharma A/S shares last traded at $6.58, with a volume of 19,400 shares. The business has a fifty day simple []
Why is Forward Pharma Stock Plunging During Premarket Tuesday?
06:08am, Tuesday, 07'th Sep 2021
The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket. Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Offic
FWP Stock: Over 20% Decrease Pre-Market Explanation
04:34am, Tuesday, 07'th Sep 2021
The stock price of Forward Pharma A/S (NASDAQ:FWP) fell by over 20% pre-market. This is why it happened.
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA�
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
04:40pm, Wednesday, 14'th Apr 2021
COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today repor
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
04:30pm, Tuesday, 12'th Jan 2021
COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures agains
Goldman Sachs Group Upgrades Chr. Hansen Holding A/S (OTCMKTS:CHYHY) to Neutral
02:54am, Thursday, 22'nd Oct 2020
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) was upgraded by research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports. A nu
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) Given Consensus Recommendation of “Hold” by Analysts
03:14am, Wednesday, 21'st Oct 2020
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) has been assigned a consensus rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat reports. Three equities research analyst
Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.65%
12:00am, Friday, 16'th Oct 2020
Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.65%
Analysts Set Ascendis Pharma A/S (NASDAQ:ASND) Price Target at $176.50
05:44am, Thursday, 15'th Oct 2020
Shares of Ascendis Pharma A/S (NASDAQ:ASND) have earned a consensus rating of “Buy” from the fourteen research firms that are presently covering the company, Marketbeat.com reports. One analyst ha
Nuveen Asset Management LLC Has $1.79 Million Position in Ascendis Pharma A/S (NASDAQ:ASND)
08:14am, Wednesday, 14'th Oct 2020
Nuveen Asset Management LLC lowered its position in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 31.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The